Société Bausch Health Companies Inc Nyse
Actions
CA91911K1021
Produits pharmaceutiques
Métier
Ventes par activité
CAD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Bausch + Lomb/International
47,3
%
| 4 905 | 46,4 % | 5 596 | 47,3 % | +14,07 % |
Salix
25,7
%
| 2 721 | 25,7 % | 3 037 | 25,7 % | +11,61 % |
International
12,2
%
| 1 286 | 12,2 % | 1 446 | 12,2 % | +12,38 % |
Diversified
10,8
%
| 1 273 | 12,0 % | 1 273 | 10,8 % | -0,04 % |
Solta Medical
4,0
%
| 391 | 3,7 % | 468 | 4,0 % | +19,92 % |
Ventes par région
CAD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States and Puerto Rico
59,3
%
| 6 296 | 59,5 % | 7 010 | 59,3 % | +11,35 % |
Other
11,5
%
| 1 155 | 10,9 % | 1 365 | 11,5 % | +18,17 % |
China
5,0
%
| 538 | 5,1 % | 595 | 5,0 % | +10,70 % |
Canada
4,2
%
| 457 | 4,3 % | 494 | 4,2 % | +8,10 % |
Mexico
3,7
%
| 359 | 3,4 % | 435 | 3,7 % | +20,95 % |
Poland
3,6
%
| 362 | 3,4 % | 431 | 3,6 % | +18,96 % |
France
2,4
%
| 264 | 2,5 % | 289 | 2,4 % | +9,29 % |
Japan
2,2
%
| 260 | 2,5 % | 262 | 2,2 % | +0,56 % |
Germany
1,7
%
| 191 | 1,8 % | 205 | 1,7 % | +7,20 % |
Russia
1,7
%
| 236 | 2,2 % | 200 | 1,7 % | -15,23 % |
United Kingdom
1,4
%
| 150 | 1,4 % | 169 | 1,4 % | +12,69 % |
South Korea
1,1
%
| 100 | 0,9 % | 126 | 1,1 % | +25,22 % |
Spain
1,1
%
| 109 | 1,0 % | 124 | 1,1 % | +13,55 % |
Italy
1,0
%
| 99 | 0,9 % | 116 | 1,0 % | +17,32 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/05/22 |
Chief Operating Officer | - | - | |
Tage Ramakrishna
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/11 |
Investor Relations Contact | - | 19/06/17 | |
Human Resources Officer | - | 01/01/19 | |
Jeff Hartness
LAW | General Counsel | - | - |
Dennis Asharin
PRN | Corporate Officer/Principal | - | 01/01/07 |
Treasurer | 48 | - | |
Corporate Officer/Principal | 59 | 08/08/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/08 |
John Paulson
CHM | Chairman | 68 | 01/06/17 |
Steven Miller
BRD | Director/Board Member | 35 | 17/03/21 |
Richard Mulligan
BRD | Director/Board Member | 69 | 06/05/22 |
Brett Icahn
BRD | Director/Board Member | 44 | 17/03/21 |
Sarah Kavanagh
BRD | Director/Board Member | 67 | 22/07/16 |
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
Amy Wechsler
BRD | Director/Board Member | 54 | 14/06/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 360 989 744 | 352 105 309 ( 97,54 %) | 0 | 97,54 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
BAUSCH + LOMB CORPORATION 88,45% | 310 449 643 | 88,45% | 4 762 297 524 $ |
Coordonnées société
Bausch Health Cos., Inc.
2150 St. Elzéar Boulevard West
H7L 4A8, Laval
+514 744 6792
http://www.bauschhealth.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Bausch & Lomb India Pvt Ltd.
Bausch & Lomb India Pvt Ltd. Electronic ComponentsElectronic Technology Part of Bausch Health Cos., Inc., Bausch & Lomb India Pvt Ltd. is a company that specializes in providing soft contact lenses and lens care products. The company was founded in 2000. The company is based in Gurgaon, India. The Indian company's main focus is to help people see better and live better by providing soft contact lenses that are specifically shaped to focus light into the retina of the eye. Additionally, Bausch + Lomb offers a complete line of soft contact lens care products designed to make the lens wearing experience healthy and comfortable. |
Electronic Components
|
Medical Specialties
|
Secteur
Ventes par activité
Ventes par région
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32 % | 815 Md | |
-6,75 % | 352 Md | |
+13,56 % | 314 Md | |
+10,68 % | 303 Md | |
+16,57 % | 242 Md | |
+2,04 % | 224 Md | |
+13,31 % | 218 Md | |
+8,48 % | 168 Md | |
-2,81 % | 159 Md |